These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Structural ensemble in computational drug screening. Fukunishi Y Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):835-49. PubMed ID: 20465522 [TBL] [Abstract][Full Text] [Related]
8. Ensemble Docking in Drug Discovery. Amaro RE; Baudry J; Chodera J; Demir Ö; McCammon JA; Miao Y; Smith JC Biophys J; 2018 May; 114(10):2271-2278. PubMed ID: 29606412 [TBL] [Abstract][Full Text] [Related]
9. Flexible receptor docking for drug discovery. Wong CF Expert Opin Drug Discov; 2015; 10(11):1189-200. PubMed ID: 26313123 [TBL] [Abstract][Full Text] [Related]
10. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Huang SY; Zou X Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427 [TBL] [Abstract][Full Text] [Related]
12. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. Duffy BC; Zhu L; Decornez H; Kitchen DB Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure. Zhang G; Wang K; Li XD; Zhang DL; Xu F Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557 [TBL] [Abstract][Full Text] [Related]
14. Docking simulations between drugs and HLA molecules associated with idiosyncratic drug toxicity. Hirayama N Drug Metab Pharmacokinet; 2017 Feb; 32(1):31-39. PubMed ID: 27964952 [TBL] [Abstract][Full Text] [Related]
15. Understanding the challenges of protein flexibility in drug design. Antunes DA; Devaurs D; Kavraki LE Expert Opin Drug Discov; 2015 Dec; 10(12):1301-13. PubMed ID: 26414598 [TBL] [Abstract][Full Text] [Related]
16. Structure-based drug metabolism predictions for drug design. Sun H; Scott DO Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193 [TBL] [Abstract][Full Text] [Related]
18. Toward in silico structure-based ADMET prediction in drug discovery. Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716 [TBL] [Abstract][Full Text] [Related]
19. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Meanwell NA Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149 [TBL] [Abstract][Full Text] [Related]
20. Using reverse docking for target identification and its applications for drug discovery. Lee A; Lee K; Kim D Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]